Travoprost Ophthalmic Solution Solution/ Drops
Product Images NDC 62332-625

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Travoprost Ophthalmic Solution (NDC 62332-625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Travo-2-5-ml-bottle (Travo 2 5 mL Bottle)

Label for Travoprost Ophthalmic Solution USP 0.004%, an ophthalmic solution containing 0.04 mg/mL travoprost. The sterile solution comes in a 2.5 mL bottle, manufactured by Alembic Pharmaceuticals Inc. Storage instructions indicate 2° to 25°C. The label includes an eye graphic and barcode.*

FDA Label Image

Travo-2-5-ml-carton (Travo 2 5 mL Carton)

Packaging label for Travoprost Ophthalmic Solution USP 0.004%, an ionic buffered solution for topical eye use. The 2.5 mL bottle is shown with a purple and green color scheme and includes manufacturer information for Alembic Pharmaceuticals Inc. Directions for storage (20° to 25°C) and usage are printed, along with warnings to keep out of reach of children. The label displays the NDC 62332-625-02 and a barcode.*

FDA Label Image

Travo-5-ml-bottle (Travo 5 mL Bottle)

Label of Travoprost Ophthalmic Solution USP 0.004% (0.04 mg/mL) in a 5 mL sterile bottle. The label includes dosage form as an ionic buffered solution for topical eye use, and indicates it is manufactured by Alembic Pharmaceuticals Inc., Bedminster, NJ, USA, with product origin from India. Storage instructions specify 2° to 25°C (36° to 77°F).*

FDA Label Image

Travo-5-ml-carton (Travo 5 mL Carton)

Carton label for Travoprost Ophthalmic Solution USP 0.004% (Ionic Buffered Solution) in 5 mL bottles. The label shows it is a sterile, prescription ophthalmic drug manufactured by Alembic Pharmaceuticals Inc. and Alembic Pharmaceuticals Limited. Storage instructions, dosage recommendation for topical eye use, and batch coding area are included. NDC 62332-625-05.*

FDA Label Image

Travo-structure (Travo Structure)

Chemical structure of Travoprost, the active ingredient in Travoprost ophthalmic solution 0.04 mg/mL by Alembic Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.